Unbridled drugflation, or a point-in-time measure of the rising cost of pharmacy benefits, is taking its toll on corporate bottom lines and household budgets.
Wendy Barnes
Advertisement
Articles by Wendy Barnes
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
4
Accelerated Approval of Cancer Drugs: Benefit or Burden?
5
